Summary of the MHRA Good Distribution Practice Symposium 2023

Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Just recently, you could read about the Good Manufacturing and Distribution Practice Symposia 2023, organized by the Medicines and Healthcare products Regulatory Agency (MHRA) on 21 and 22 February 2023. The first day of the conference focused on regulatory developments in the area of Good Distribution Practice (GDP).
A summary of the GDP part was now published on the MHRA Inspectorate blog. The article dated 02 May 2023 was written by Manuela Krasteva. In the introduction, she states that "the event included a variety of topics with a special emphasis on updates on our regulatory position and the MHRA’s role as a sovereign regulator. The theme of the day was largely influenced by the changes following the UK’s departure from the EU."
The blog post goes on, giving a brief summary of the individual contributions. Among the topics presented were the environmental changes and their impact on GDP activities, as well as the role of the so-called Responsible Person (Import), RPi.
To read the full article, please see the MHRA Inspectorate blog "MHRA Good Distribution Practice Symposium 2023".
Related GMP News
15.07.2025New Swissmedic Technical Interpretation on Returns of Medicinal Products
15.07.2025Two new GDP Non-Compliance Reports from Austria and Ireland published in the EudraGMDP database
15.07.2025Reminder: Participate in the GDP Implementation Survey until 31 July 2025
15.07.2025PDA Publishes Results of Transportation Validation Benchmarking Survey
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms